Venkatesan Jay's Form 4/A amendment
AmendedElicio Therapeutics, Inc. (ELTX) · filed Jan 2, 2025
- Accession no.
- 0001601485-25-000002
- Filed
- Jan 2, 2025
- Trade date
- Jun 28, 2024
- Filing delay
- 188 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Jul 2, 2024
This filing lists 0 non-derivative transactions and 8 derivative transactions. It was filed 188 days after the trade.
This amendment replaces 0001140361-24-032293 (filed Jul 2, 2024).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Venkatesan JayCIK 0001413350 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 28, 2024 | Common Stock | PPurchaseAcquired | +50,000 | $0.00 | $0 | 50,000 | Indirect | |
| Jun 28, 2024 | Common Stock | PPurchaseAcquired | +50,000 | $4.99 | +$249,500 | 50,000 | Indirect | |
| Jun 28, 2024 | Common Stock | PPurchaseAcquired | +50,000 | $0.00 | $0 | 50,000 | Indirect | |
| Jun 28, 2024 | Common Stock | PPurchaseAcquired | +50,000 | $4.99 | +$249,500 | 50,000 | Indirect | |
| Jun 28, 2024 | Common Stock | PPurchaseAcquired | +50,000 | $0.00 | $0 | 50,000 | Indirect | |
| Jun 28, 2024 | Common Stock | PPurchaseAcquired | +50,000 | $4.99 | +$249,500 | 50,000 | Indirect | |
| Jun 28, 2024 | Common Stock | PPurchaseAcquired | +50,000 | $0.00 | $0 | 50,000 | Direct | |
| Jun 28, 2024 | Common Stock | PPurchaseAcquired | +50,000 | $4.99 | +$249,500 | 50,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.